TerrAscend (TSNDF) Interest Expenses (2020 - 2026)
TerrAscend (TSNDF) posted quarterly Interest Expenses of $121.2 million for Q1 2026, up 5.83% year-over-year from $114.5 million in Q1 2025, and up 867.0% quarter-over-quarter from -$15.8 million in Q4 2025.
TerrAscend (TSNDF) Interest Expenses (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Interest Expenses for 7 consecutive years, with $121.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 5.83% year-over-year to $121.2 million; the TTM figure through Mar 2026 stood at $121.2 million (up 5.83% YoY), while the FY2025 annual figure was $112.1 million, up 307.8% from the prior year.
- Interest Expenses rose to $121.2 million in Q1 2026 per TSNDF's latest filing, from -$15.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $133.1 million in Q2 2024 and bottomed at -$15.8 million in Q4 2025.
- Historically, Interest Expenses has averaged $40.5 million across 5 years, with a median of $8.5 million in 2023.
- On a YoY basis, Interest Expenses climbed as much as 1523.52% in 2025 and fell as far as 265.24% in 2025.
- TerrAscend's Interest Expenses stood at $6.2 million in 2022, then surged by 132.71% to $14.4 million in 2023, then slumped by 33.68% to $9.6 million in 2024, then sank by 265.24% to -$15.8 million in 2025, then soared by 867.0% to $121.2 million in 2026.
- Business Quant data shows TSNDF's Interest Expenses at $121.2 million in Q1 2026, -$15.8 million in Q4 2025, and $119.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | TerrAscend | 187.17 Mn | 145.05 Mn | 36.25 Mn | 7.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121.01 Mn |
| Jun 30, 2026 | 121.01 Mn |
| Mar 31, 2026 | 121.22 Mn |
| Mar 31, 2026 | 121.22 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Sep 30, 2025 | 119.22 Mn |
| Sep 30, 2025 | 119.22 Mn |
| Jun 30, 2025 | 119.22 Mn |
| Jun 30, 2025 | 119.22 Mn |
| Mar 31, 2025 | 114.54 Mn |
| Mar 31, 2025 | 114.54 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.07 Mn |